Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

NCT01159964 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
60
Enrollment
INDUSTRY
Sponsor class

Stopped Study termination due to negative Phase III of another study product from same technology platform.

Conditions

Interventions

Sponsor

GlaxoSmithKline